Donate

Let’s Talk About It: Ovarian Cancer Recurrence

recurrence cancer

Hearing your cancer has returned can feel scary. These slides talk about facing the road ahead after a recurrence of ovarian cancer. From close communication with your medical team to finding the right type of support so you feel less alone, we can help find your footing one step at a time.

Management of Breast Cancer Brain Metastases

manage b c

As systemic control improves and there is more routine surveillance imaging, breast cancer brain metastases (BCBM) are becoming an increasingly common diagnosis. In this webinar, Dr. Aixa Soyano, Assistant Member in the Department of Breast Oncology at the Moffitt Cancer Center, and Dr. Kamran Ahmed, radiation oncologist at Moffitt Cancer Center, discuss their research and […]

Ask the Expert: Rare Ovarian Cancers

maggie na

We’re excited to welcome back Dr. Amanda Nickles Fader, Director of the Center for Rare Gynecologic Cancers at The Johns Hopkins Hospital, to answer viewers’ questions on rare ovarian cancers. https://www.youtube.com/watch?v=MBfqZGW1-SI

Let’s Talk About It: TNBC Ask me Anything: Long-Term Side Effects of Cancer Treatment

amelia

Dr. Daniela Stan, Director of Breast Clinic Survivorship at Mayo Clinic in Rochester, MN, and Dr. Amelia Zelnak, Breast Oncologist at Atlanta Cancer Care in Atlanta, GA, answer questions and delve into the realities of long-term side effects and address living a healthy lifestyle, enhancing quality of life, and reducing symptoms for cancer survivors. https://www.youtube.com/watch?v=a-Jbn1lwa9E

Everything You Want to Know About PARP Inhibitors

ovarian problem

PARP inhibitors have revolutionized ovarian cancer treatment and provided hope for so many patients. At the same time, a lot of questions often come up about their use: when should they be used? How long can they be taken for? PARP after PARP? Dr. Kathleen Moore, Director of the Oklahoma TSET Phase I Program at […]

Patient-Centered Dosing for Individuals with MBC

patient centered

Join the Patient-Centered Dosing Initiative (PCDI)’s Dr. Aditya Bardia, medical oncologist at Massachusetts General Hospital (MGH) Cancer Center and Assistant Professor of Medicine at Harvard Medical School, and Anne Loeser, patient advocate, author of The Insider’s Guide to Metastatic Breast Cancer, to discuss their work with patients and doctors to help select optimal treatment dosage […]

Rare Ovarian Cancers

ovarian cancer

Dr. Amanda Nickles Fader, Director of the Center for Rare Gynecologic Cancers at The Johns Hopkins Hospital, discusses new research on and treatment of rare types of ovarian cancer, with a focus on low grade serous and clear cell ovarian cancers. https://www.youtube.com/watch?v=4fnLum4Gw_0

MBC 101: What Happens Now?

mbc 101

Dr. Diana Lake, Medical Oncologist, Memorial Sloan Kettering Cancer Center, explains the basics of metastatic breast cancer including when should you begin to worry as an early-stage patient, diagnostic tests, sub-types and treatment options for each type of metastatic breast cancer. Christine Benjamin, SHARE’s Senior Director of Patient Services and Education, offers her perspective on […]

Donate